However, it is unknown if the enhanced insulin sensitivities lead to enhanced mitochondrial functions and biogenesis or visa versa, but enhancing insulin sensitivities and mitochondria functions plus promoting mitochondrial biogenesis are common goals for prevention and treatment of both type 2 diabetes and obesity [10]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.